FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175930411> ?p ?o ?g. }

• W3175930411 endingPage "e0009060" @default.
• W3175930411 startingPage "e0009060" @default.
• W3175930411 abstract "Melioidosis, an often-fatal infectious disease caused by the environmental Gram-negative bacillus Burkholderia pseudomallei, is endemic in tropical countries. Diabetes mellitus and environmental exposure are important risk factors for melioidosis acquisition. We aim to evaluate the effectiveness of a multifaceted prevention programme for melioidosis in diabetics in northeast Thailand.From April 2014 to December 2018, we conducted a stepped-wedge cluster-randomized controlled behaviour change trial in 116 primary care units (PCUs) in Ubon Ratchathani province, northeast Thailand. The intervention was a behavioural support group session to help diabetic patients adopt recommended behaviours, including wearing rubber boots and drinking boiled water. We randomly allocated the PCUs to receive the intervention starting in March 2016, 2017 and 2018. All diabetic patients were contacted by phone yearly, and the final follow-up was December 2018. Two primary outcomes were hospital admissions involving infectious diseases and culture-confirmed melioidosis. Of 9,056 diabetics enrolled, 6,544 (72%) received a behavioural support group session. During 38,457 person-years of follow-up, we observed 2,195 (24%) patients having 3,335 hospital admissions involved infectious diseases, 80 (0.8%) melioidosis, and 485 (5%) deaths. In the intention-to-treat analysis, implementation of the intervention was not associated with primary outcomes. In the per-protocol analysis, patients who received a behavioural support group session had lower incidence rates of hospital admissions involving infectious diseases (incidence rate ratio [IRR] 0.89; 95%CI 0.80-0.99, p = 0.03) and of all-cause mortality (IRR 0.54; 95%CI 0.43-0.68, p<0.001). However, the incidence rate of culture-confirmed melioidosis was not significantly lower (IRR 0.96, 95%CI 0.46-1.99, p = 0.66).Clear benefits of this multifaceted prevention programme for melioidosis were not observed. More compelling invitations for the intervention, modification of or addition to the behaviour change techniques used, and more frequent intervention may be needed.This trial is registered with ClinicalTrials.gov, number NCT02089152." @default.
• W3175930411 created "2021-07-05" @default.
• W3175930411 creator A5000833988 @default.
• W3175930411 creator A5024508211 @default.
• W3175930411 creator A5041055679 @default.
• W3175930411 creator A5045288345 @default.
• W3175930411 creator A5058967121 @default.
• W3175930411 creator A5060555434 @default.
• W3175930411 creator A5090631705 @default.
• W3175930411 date "2021-06-25" @default.
• W3175930411 modified "2023-10-17" @default.
• W3175930411 title "Effectiveness of a multifaceted prevention programme for melioidosis in diabetics (PREMEL): A stepped-wedge cluster-randomised controlled trial" @default.
• W3175930411 cites W144619522 @default.
• W3175930411 cites W2000192273 @default.
• W3175930411 cites W2017178514 @default.
• W3175930411 cites W2045384215 @default.
• W3175930411 cites W2055690472 @default.
• W3175930411 cites W2077109464 @default.
• W3175930411 cites W2107966948 @default.
• W3175930411 cites W2109942009 @default.
• W3175930411 cites W2116262659 @default.
• W3175930411 cites W2136608905 @default.
• W3175930411 cites W2149156757 @default.
• W3175930411 cites W2169843341 @default.
• W3175930411 cites W2276086324 @default.
• W3175930411 cites W2407415576 @default.
• W3175930411 cites W2462797431 @default.
• W3175930411 cites W2494548181 @default.
• W3175930411 cites W2594511273 @default.
• W3175930411 cites W2755253751 @default.
• W3175930411 cites W2883429584 @default.
• W3175930411 cites W2886428084 @default.
• W3175930411 cites W2890709884 @default.
• W3175930411 cites W2969806150 @default.
• W3175930411 cites W2990844948 @default.
• W3175930411 cites W2998853022 @default.
• W3175930411 cites W4211093779 @default.
• W3175930411 cites W4290049805 @default.
• W3175930411 doi "https://doi.org/10.1371/journal.pntd.0009060" @default.
• W3175930411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8266097" @default.
• W3175930411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34170931" @default.
• W3175930411 hasPublicationYear "2021" @default.
• W3175930411 type Work @default.
• W3175930411 sameAs 3175930411 @default.
• W3175930411 citedByCount "10" @default.
• W3175930411 countsByYear W31759304112022 @default.
• W3175930411 countsByYear W31759304112023 @default.
• W3175930411 crossrefType "journal-article" @default.
• W3175930411 hasAuthorship W3175930411A5000833988 @default.
• W3175930411 hasAuthorship W3175930411A5024508211 @default.
• W3175930411 hasAuthorship W3175930411A5041055679 @default.
• W3175930411 hasAuthorship W3175930411A5045288345 @default.
• W3175930411 hasAuthorship W3175930411A5058967121 @default.
• W3175930411 hasAuthorship W3175930411A5060555434 @default.
• W3175930411 hasAuthorship W3175930411A5090631705 @default.
• W3175930411 hasBestOaLocation W31759304111 @default.
• W3175930411 hasConcept C120665830 @default.
• W3175930411 hasConcept C121332964 @default.
• W3175930411 hasConcept C126322002 @default.
• W3175930411 hasConcept C142724271 @default.
• W3175930411 hasConcept C164866538 @default.
• W3175930411 hasConcept C167704817 @default.
• W3175930411 hasConcept C168563851 @default.
• W3175930411 hasConcept C176400912 @default.
• W3175930411 hasConcept C187212893 @default.
• W3175930411 hasConcept C194828623 @default.
• W3175930411 hasConcept C199360897 @default.
• W3175930411 hasConcept C2779110727 @default.
• W3175930411 hasConcept C2779775996 @default.
• W3175930411 hasConcept C41008148 @default.
• W3175930411 hasConcept C44249647 @default.
• W3175930411 hasConcept C523546767 @default.
• W3175930411 hasConcept C54355233 @default.
• W3175930411 hasConcept C61511704 @default.
• W3175930411 hasConcept C71924100 @default.
• W3175930411 hasConcept C86803240 @default.
• W3175930411 hasConceptScore W3175930411C120665830 @default.
• W3175930411 hasConceptScore W3175930411C121332964 @default.
• W3175930411 hasConceptScore W3175930411C126322002 @default.
• W3175930411 hasConceptScore W3175930411C142724271 @default.
• W3175930411 hasConceptScore W3175930411C164866538 @default.
• W3175930411 hasConceptScore W3175930411C167704817 @default.
• W3175930411 hasConceptScore W3175930411C168563851 @default.
• W3175930411 hasConceptScore W3175930411C176400912 @default.
• W3175930411 hasConceptScore W3175930411C187212893 @default.
• W3175930411 hasConceptScore W3175930411C194828623 @default.
• W3175930411 hasConceptScore W3175930411C199360897 @default.
• W3175930411 hasConceptScore W3175930411C2779110727 @default.
• W3175930411 hasConceptScore W3175930411C2779775996 @default.
• W3175930411 hasConceptScore W3175930411C41008148 @default.
• W3175930411 hasConceptScore W3175930411C44249647 @default.
• W3175930411 hasConceptScore W3175930411C523546767 @default.
• W3175930411 hasConceptScore W3175930411C54355233 @default.
• W3175930411 hasConceptScore W3175930411C61511704 @default.
• W3175930411 hasConceptScore W3175930411C71924100 @default.
• W3175930411 hasConceptScore W3175930411C86803240 @default.
• W3175930411 hasFunder F4320307874 @default.
• W3175930411 hasIssue "6" @default.

• next